Arabian International Healthcare Holding Company (9530.SR)
SAR 43.0
(1.53%)
SAR 43.0
(1.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 19.4 Million | 60.18 Million | 130.41 Million | 222.76 Million | -22.07 Million |
| Net Income | 38.08 Million | 36.59 Million | 93.73 Million | 119.79 Million | 56.72 Million |
| Depreciation & Amortization | 15.28 Million | 10 Million | 7.23 Million | 7.53 Million | 7.88 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -23.55 Million | 30.79 Million | 78.84 Million | 112.36 Million | -71.26 Million |
| Other non-cash items | -10.4 Million | -17.2 Million | -49.4 Million | -16.92 Million | -15.42 Million |
| Investing Cash Flow | -31.82 Million | -79.52 Million | 4.34 Million | 6.57 Million | 9.06 Million |
| Investments in PPE | -8.21 Million | -6.41 Million | -4.03 Million | -1.43 Million | -2.32 Million |
| Acquisitions | -25.69 Million | -49.18 Million | - | 683.32 Thousand | 881.56 Thousand |
| Investment purchases | -25.69 Million | -19.3 Million | - | - | - |
| Sales/Maturities of investments | 2.08 Million | 2.9 Million | - | - | - |
| Other Investing Activities | 25.69 Million | -8.33 Million | 8.37 Million | 7.32 Million | 10.51 Million |
| Financing Cash Flow | 11.21 Million | 91.89 Million | -136.84 Million | -230.45 Million | 23.44 Million |
| Debt repayment | -39 Million | -25 Million | -25 Million | -196 Million | -45.5 Million |
| Dividends payments | -19.78 Million | -60 Million | -82.68 Million | -30.85 Million | -16.89 Million |
| Common Stock Repurchased | - | -8.06 Million | - | - | - |
| Common Stock Issuance | - | 46.06 Million | - | - | - |
| Other Financing Activities | -324.73 Thousand | -687.08 Thousand | -29.16 Million | -3.6 Million | 85.84 Million |
| Accounts receivables | -79.41 Million | 24.89 Million | 266.16 Million | 49.65 Million | -99.32 Million |
| Accounts payables | -23.33 Million | - | -131.52 Million | 12.14 Million | 116.12 Million |
| Inventory | 72.75 Million | -97.4 Million | 28.32 Million | -20.62 Million | -84.99 Million |
| Other working capital | 6.42 Million | 103.3 Million | -84.11 Million | 71.19 Million | -3.06 Million |
| Cash at beginning of period | 83.6 Million | 11.02 Million | 13.11 Million | 14.22 Million | 3.78 Million |
| Cash at end of period | 82.38 Million | 83.58 Million | 11.02 Million | 13.11 Million | 14.22 Million |
| Capital Expenditure | -8.21 Million | -6.41 Million | -4.03 Million | -1.43 Million | -2.32 Million |
| Effect of forex changes on cash | -14.56 Thousand | -42.81 Thousand | - | - | - |
| Net cash flow / Change in cash | -1.21 Million | 72.55 Million | -2.08 Million | -1.11 Million | 10.43 Million |
| Free Cash Flow | 11.19 Million | 53.77 Million | 126.38 Million | 221.33 Million | -24.4 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -15.9 Million | -15.9 Million | 30.44 Million | 38.08 Million | 30.44 Million | -22.8 Million |
| Depreciation & Amortization | 4.21 Million | 4.21 Million | 4.56 Million | 15.28 Million | 4.52 Million | 6.14 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -4680.00 | -4680.00 | 17.99 Million | -23.55 Million | 17.99 Million | -21.58 Million |
| Other non-cash items | 2.7 Million | 2.7 Million | -32.26 Million | -10.4 Million | -32.22 Million | 19 Million |
| Investing Cash Flow | -3.29 Million | -3.29 Million | -11.11 Million | -31.82 Million | -11.11 Million | -5.11 Million |
| Investments in PPE | -633.61 Thousand | -633.61 Thousand | -1.26 Million | -8.21 Million | -1.26 Million | -5.36 Million |
| Acquisitions | -4.96 Million | -4.96 Million | - | -25.69 Million | - | -1.7 Million |
| Investment purchases | - | - | -25 Million | -25.69 Million | - | -692.73 Thousand |
| Sales/Maturities of investments | - | - | 1.14 Million | 2.08 Million | - | 942.2 Thousand |
| Other Investing Activities | 2.31 Million | 2.31 Million | -9.85 Million | 25.69 Million | -9.85 Million | 1.7 Million |
| Financing Cash Flow | 8.99 Million | 8.99 Million | -11.33 Million | 11.21 Million | -11.33 Million | 33.55 Million |
| Debt repayment | -20 Million | - | -18.49 Million | -39 Million | - | -57.49 Million |
| Dividends payments | - | - | -552.00 | -19.78 Million | - | -19.79 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 8.99 Million | 8.99 Million | -11.33 Million | -324.73 Thousand | -11.33 Million | 26.67 Million |
| Accounts receivables | 43.06 Million | 43.06 Million | -45.92 Million | -79.41 Million | -45.92 Million | 12.93 Million |
| Accounts payables | -23.32 Million | - | -21.81 Million | -23.33 Million | - | -1.51 Million |
| Inventory | -31.36 Million | -31.36 Million | 39.44 Million | 72.75 Million | 39.44 Million | -6.12 Million |
| Other working capital | -11.69 Million | -11.69 Million | 24.47 Million | 6.42 Million | 24.47 Million | -26.87 Million |
| Cash at beginning of period | 82.38 Million | - | 85.79 Million | 83.6 Million | - | 83.6 Million |
| Cash at end of period | 75.8 Million | -3.28 Million | 82.38 Million | 82.38 Million | -1.7 Million | 85.79 Million |
| Capital Expenditure | -633.61 Thousand | -633.61 Thousand | -1.26 Million | -8.21 Million | -1.26 Million | -5.36 Million |
| Effect of forex changes on cash | - | - | - | -14.56 Thousand | - | -100 Thousand |
| Net cash flow / Change in cash | -6.57 Million | -3.28 Million | -3.41 Million | -1.21 Million | -1.7 Million | 2.19 Million |
| Free Cash Flow | -9.62 Million | -9.62 Million | 19.48 Million | 11.19 Million | 19.48 Million | -31.59 Million |
1618
ZFCVINDIA
5355
THEMISMED
8929
GZTGF